Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000932471-25-000733·SELLAS Life Sciences Group, Inc.
Schedule 13G ownership disclosure
SELLAS Life Sciences Group Inc
Common Stock · CUSIP: 81642T209
Event date: 2025-06-30
- Filing-level shares
- 6,694,799
- Percent of class
- 6.70%
- The Vanguard Group
Shares: 6,694,799 · Class: 6.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000733
- Form type
- SCHEDULE 13G
- Filer
- SELLAS Life Sciences Group, Inc.
- CIK
- CIK 1390478
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership